GL-ONC1 Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
- Status
- RECRUITING
- Phase
- N/A
A Phase I Study of WT1 or NY-ESO-1 Vaccine and Nivolumab For Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host
- Status
- RECRUITING
- Phase
- N/A
Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane
- Status
- COMPLETED
- Phase
- PHASE3
Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer: a Retrospective Study
- Status
- UNKNOWN
- Phase
- N/A
Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)
- Status
- TERMINATED
- Phase
- PHASE3
MR-HIFU for Recurrent Gynaecological Cancer
- Status
- COMPLETED
- Phase
- NA
A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer
- Status
- UNKNOWN
- Phase
- N/A
Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)
- Status
- COMPLETED
- Phase
- NA
Treatment for Malignant Ovarian Cancer: Laparoscopy vs Laparotomy
- Status
- UNKNOWN
- Phase
- NA
Study to Evaluate PM01183 in Combination With Olaparib in Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Study of the Isotopic Distribution of Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Ovarian Origin
- Status
- WITHDRAWN
- Phase
- NA
Targeted Next-generation Sequencing Panel for Identification of Germline Mutations in Early Onset Cancers With Sporadic or Hereditary Presentation
- Status
- TERMINATED
- Phase
- NA